More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

Vasant Narasimhan, MD, took the helm of Novartis on February 1, 2018, assuming the role of CEO following the retirement of former CEO Joseph Jimenez. So what does the new CEO face? Key for Narasimhan will be to drive growth in the company's...

In its annual assessment of technology advances, Accenture highlights that rapid advancements in technologies, including artificial intelligence, advanced analytics and the cloud, are enabling companies to not just create innovative products and...

What do parenteral drugs and healthcare reform have in common? Recent reports point to the relationship between the high cost of specialty drugs, often parenteral drugs administered in hospitals. So what did the reports show and what are the...

Small molecules remain the dominant modality in pharmaceuticals based on approvals of new molecular entities (NMEs), but biologics continue to make inroads. So what do the numbers show? Small molecules accounted for nearly three-fourths of NME...

A recent study from Accenture and HFS Research points to the need to have “intelligent operations” to drive business outcomes. So what is a winning approach for “intelligent operations?” The study surveyed nearly 500 executives to analyze the...

Policymakers and the biopharmaceutical industry have been discussing the opportunity of biosimilars for more than a decade, but where do biosimilars stand today? The opportunities loom larger than ever today, with about $100 billion worth of...

Which executives and other leaders may have the largest impact for the pharmaceutical industry in 2018? DCAT Value Chain Insights offers a top ten ranking. Which executives should be on your radar in 2018? DCAT Value Chain Insights examines some...

So what is on the minds of CEOs? PwC’s annual study released this week at the World Economic Forum in Davos, Switzerland shows a record-breaking level of optimism among CEOs about global economic prospects, at least in the short term. So what did...